Focus Partners Wealth
ALT icon

Focus Partners Wealth’s Altimmune ALT Stock Holding History

Focus Partners Wealth’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38K Buy
+12,499
New +$37.3K ﹤0.01% 2697
2025
Q1 		– Sell
-122,539
Closed -$884K – 1905
2024
Q4 		$884K Buy
+122,539
New +$936K ﹤0.01% 1095

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Focus Partners Wealth's ALT Position: Q2 2026 in Review

Focus Partners Wealth opened a new position in Altimmune (ALT) in Q2 2026: 12,499 shares worth $38K. The stake represents ﹤0.01% of the portfolio and ranks #2697 among its holdings. This is a return to the name: Focus Partners Wealth previously reported a position in ALT as recently as Q4 2024.

Focus Partners Wealth first reported a position in ALT in Q4 2024 and has held it in 2 quarters since. The position peaked at $884K in Q4 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Focus Partners Wealth held 12,499 shares of Altimmune worth $38K as of Q2 2026.
  • Altimmune was a new Focus Partners Wealth position in Q2 2026.
  • Altimmune made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2697 holding.
  • Focus Partners Wealth first reported a position in Altimmune in Q4 2024 and has held it in 2 quarters since.
  • Focus Partners Wealth's Altimmune position peaked at $884K in Q4 2024.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.